Christopher Landowski

Christopher Landowski is a seasoned professional in the field of biotechnology and pharmaceutical sciences, currently serving as Co-Founder and CTO at Onego Bio since February 2022. Landowski has held the position of Principal Scientist at VTT Technical Research Centre of Finland since 2008, where the focus is on harnessing the filamentous fungus Trichoderma reesei for the production of therapeutic proteins and industrial enzymes. Prior experience includes research roles at Universität Bern, Harvard Medical School, the University of Michigan, and Promega, covering areas such as membrane transport proteins, calcium entry channels, and drug delivery systems. Landowski earned a PhD in Pharmaceutical Sciences from the University of Michigan and a BS in Biochemistry from the University of Wisconsin-Madison.